MRK logo

MRK
Merck & Co Inc

25,632
Mkt Cap
$344.97B
Volume
3.11M
52W High
$105.84
52W Low
$73.31
PE Ratio
12.91
MRK Fundamentals
Price
$98.50
Prev Close
$97.62
Open
$98.45
50D MA
$91.36
Beta
0.31
Avg. Volume
15.31M
EPS (Annual)
$6.74
P/B
4.68
Rev/Employee
$852,973.33
Loading...
Loading...
News
all
press releases
Merck & Co., Inc. $MRK Stock Position Decreased by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company decreased its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 21.8% during the 2nd quarter, according to the company in its most recent 13F filing with...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth
ABBV's expanding oncology lineup, spanning new solid tumor drugs and rising Venclexta sales, is helping drive steady top-line growth.
Zacks·3h ago
News Placeholder
BNP Paribas Lowers Stake in Merck & Co., Inc. $MRK
BNP Paribas cut its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 27.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The...
MarketBeat·6h ago
News Placeholder
EDENTREE ASSET MANAGEMENT Ltd Purchases 15,000 Shares of Merck & Co., Inc. $MRK
EDENTREE ASSET MANAGEMENT Ltd increased its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 14.2% in the 2nd quarter, according to the company in its most recent 13F filing with...
MarketBeat·7h ago
News Placeholder
Merck & Co Unusual Options Activity
read more...
Benzinga·23h ago
News Placeholder
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2% - Here's What Happened
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2% - Time to Sell...
MarketBeat·2d ago
News Placeholder
Pharma ETFs to Gain From Landmark UK-US Zero-Tariff Deal
Pharma ETFs like IHE are poised to surge as the UK-US zero-tariff deal raises UK drug prices and strengthens major U.S. players' outlook.
Zacks·2d ago
News Placeholder
MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?
Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.
Zacks·2d ago
News Placeholder
MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?
Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.
Zacks·2d ago
News Placeholder
WINTON GROUP Ltd Makes New $3.79 Million Investment in Merck & Co., Inc. $MRK
WINTON GROUP Ltd bought a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The firm bought 47,854 shares of the...
MarketBeat·2d ago

Latest MRK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.